Dr Liberti has worked in the fields of pharmaceutical regulatory affairs, communications and clinical R&D for the past four decades. He began his career at Wyeth Laboratories working in product development, then as a regulatory writer in clinical R&D, and manager of safety surveillance in medical affairs. He served as the editorial director for the North American operations of ADIS international after which he founded PIA Ltd, a company specialising in regulatory writing and consulting; he co-founded Astrolabe Analytica under which he helped develop, patent and commercialise the Astrolabe Message Mapping System.TM
Since 2009 he has served as the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd). He has been actively involved in promulgating best practices in the regulatory aspects of medicines development, especially in the emerging markets.
Dr Liberti received his doctorate in International Regulatory Policy through the WHO Collaborating Centre for Pharmaceutical Policy and Regulation based in the Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands, where his research centred on expedited regulatory pathways with applicability in the emerging markets. He received both his bachelor of science in pharmacy and master’s degree in pharmacognosy from the Philadelphia College of Pharmacy and Science (now the University of the Sciences in Philadelphia). He attained the status of Regulatory Affairs Certified (RAC) with the Regulatory Affairs Professional Society and was awarded an honorary Doctor of Science degree by his alma mater. He is a Fellow of the American Medical Writers Association and is a recipient of their Golden Apple award for excellence in teaching. Dr Liberti is a co-founder of the Erudee Foundation, a non-profit dedicated to supporting local post-secondary educational opportunities for students in Latin America and Africa.